Abstract
Neuroanatomical abnormalities have been reported along a continuum from at-risk stages, including high schizotypy, to early and chronic psychosis. However, a comprehensive neuroanatomical mapping of schizotypy remains to be established. The authors conducted the first large-scale meta-analyses of cortical and subcortical morphometric patterns of schizotypy in healthy individuals, and compared these patterns with neuroanatomical abnormalities observed in major psychiatric disorders. The sample comprised 3,004 unmedicated healthy individuals (12-68 years, 46.5% male) from 29 cohorts of the worldwide ENIGMA Schizotypy working group. Cortical and subcortical effect size maps with schizotypy scores were generated using standardized methods. Pattern similarities were assessed between the schizotypy-related cortical and subcortical maps and effect size maps from comparisons of schizophrenia (SZ), bipolar disorder (BD) and major depression (MDD) patients with controls. Thicker right medial orbitofrontal/ventromedial prefrontal cortex (mOFC/vmPFC) was associated with higher schizotypy scores (r=.07, pFDR=.02). The cortical thickness profile in schizotypy was positively correlated with cortical abnormalities in SZ (r=.33, pspin=.01), but not BD (r=.19, pspin=.16) or MDD (r=-.22, pspin=.10). The schizotypy-related subcortical volume pattern was negatively correlated with subcortical abnormalities in SZ (rho=-.65, pspin=.01), BD (rho=-.63, pspin=.01), and MDD (rho=-.69, pspin=.004). Comprehensive mapping of schizotypy-related brain morphometry in the general population revealed a significant relationship between higher schizotypy and thicker mOFC/vmPFC, in the absence of confounding effects due to antipsychotic medication or disease chronicity. The cortical pattern similarity between schizotypy and schizophrenia yields new insights into a dimensional neurobiological continuity across the extended psychosis phenotype.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Core funding for ENIGMA was provided by the NIH Big Data to Knowledge (BD2K) program under consortium grant U54 EB020403 (PI: Paul M Thompson). GM is supported by a Sir Henry Dale Fellowship jointly funded by the Wellcome Trust and the Royal Society (grant number 202397/Z/16/Z). Acknowledgments and funding details for the various participating data contributors are listed in at the end of the Supplement.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Each study sample was collected with participants written informed consent approved by local Institutional Review Boards (IRB). The details of the IRB/oversight body that provided approval or exemption for the research described are given below. Ethical approval was given by the following boards/committees: Institute of Psychiatry Research Ethics Committee at King's College London, Institutional Review Board of University of Muenster, Institutional Review Board of Chinese Academy of Sciences, Institutional Review Board of Monash University Institutional Review Board of Philipps-University Marburg, Institutional Review Board of University of Bonn, Institutional Review Board of University of London, Institutional Review Board of University of Geneva, Institutional Review Board of University of Auckland, Ethics Committee of the Mental Health Research Center, Moscow, Institutional Review Board of McGill University, Institutional Review Board of University of Roehampton, Institutional Review Board of Jena University Hospital, Institutional Review Board of Donald and Barbara Zucker School of Medicine at Hofstra University/Northwell, Institutional Review Board of University of Amsterdam, Ethic Commission Zurich, Institutional Review Board of Brunel University London, Institutional Review Board of University of Groningen, Human Research Ethics Committee at University of Melbourne.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Data are available from the authors upon request with permission from the chairs and members of the ENIGMA Schizotypy Working Group.
